|
1）Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012; 366(6): 539-51
|
|
|
|
2）Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012; 22(1): 21-30
|
|
|
|
|
3）Zen Y, Fujii T, Harada K, et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology. 2007; 45(6): 1538-46
|
|
|
|
|
|
4）Tanaka A, Moriyama M, Nakashima H, et al. Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz disease. Arthritis Rheum. 2012; 64(1): 254-63
|
|
|
|
|
|
5）Watanabe T, Yamashita K, Fujikawa S, et al. Involvement of activation of toll-like receptors and nucleotide-binding oligomerization domain-like receptors in enhanced IgG4 responses in autoimmune pancreatitis. Arthritis Rheum. 2012; 64(3): 914-24
|
|
|
|
|
|
6）Watanabe T, Yamashita K, Sakurai T, et al. Toll-like receptor activation in basophils contributes to the development of IgG4-related disease. J Gastroenterol. 2012. Jun 29 [Epub ahead of print]
|
|
|
|
|
|
7）Kiyama K, Kawabata D, Hosono Y, et al. Serum BAFF and APRIL levels in patients with IgG4-related disease and their clinical significance. Arthritis Res Ther. 2012; 14(2): R86
|
|
|
|
|
|
8）Nakashima H, Miyake K, Moriyama M, et al. An amplification of IL-10 and TGF-beta in patients with IgG4-related tubulointerstitial nephritis. Clin Nephrol. 2010; 73(5): 385-91
|
|
|
|
|
|
9）Mizushima I, Yamada K, Fujii H, et al. Clinical and histological changes associated with corticosteroid therapy in IgG4-related tubulointerstitial nephritis. Mod Rheumatol. 2012 Jan 20 [Epub ahead of print]
|
|
|
|
|
|
10）Maehara T, Moriyama M, Nakashima H, et al. Interleukin-21 contributes to germinal centre formation and immunoglobulin G4 production in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease. Ann Rheum Dis. 2012. Jun 29 [Epub ahead of print]
|
|
|
|
|
|
11）Dillon SR, Gross JA, Ansell SM, et al. An APRIL to remember: novel TNF ligands as therapeutic targets. Nat Rev Drug Discov. 2006; 5(3): 235-46
|
|
|
|
|
|
12）Nishi H, Tojo A, Onozato ML, et al. Anti-carbonic anhydrase II antibody in autoimmune pancreatitis and tubulointerstitial nephritis. Nephrol Dial Transplant. 2007; 22(4): 1273-5
|
|
|
|
|
|
13）Okazaki K, Uchida K, Ohana M, et al. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology. 2000; 118(3): 573-81
|
|
|
|
|
|
14）Asada M, Nishio A, Uchida K, et al. Identification of a novel autoantibody against pancreatic secretory trypsin inhibitor in patients with autoimmune pancreatitis. Pancreas. 2006; 33(1): 20-6
|
|
|
|
|
|
15）Uchida K, Okazaki K, Nishi T, et al. Experimental immune-mediated pancreatitis in neonatally thymectomized mice immunized with carbonic anhydrase II and lactoferrin. Lab Invest. 2002; 82(4): 411-24
|
|
|
|
|
|
16）川 茂幸, 浜野英明. 特集 自己免疫性膵炎最前線 自己免疫性膵炎臨床診断基準2006の解説-3. 血清学的診断-．膵臓. 2007; 22: 641-5
|
|
|
|
|
17）Khosroshahi A, Ayalon R, Beck LH, Jr., et al. IgG4-related disease is not associated with antibody to the phospholipase A2 receptor. Int J Rheumatol. 2012; 2012: 139409 Epub 2012 May 10
|
|
|
|
|
|
18）Muraki T, Hamano H, Ochi Y, et al. Autoimmune pancreatitis and complement activation system. Pancreas. 2006; 32(1): 16-21
|
|
|
|
|
|
19）Saeki T, Nishi S, Imai N, et al. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int. 2011; 78(10): 1016-23
|
|
|
|
|
|
20）Kawano M, Saeki T, Nakashima H, et al. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol. 2011; 15: 615-26
|
|
|
|
|
|
21）山本元久，高橋裕樹，苗代康可，他．ミクリッツ病と全身性IgG4関連疾患-当科におけるsystemic IgG4-related plasmacytic syndrome (SIPS) 40例の臨床的検討から-．日臨免誌．2008; 31: 1-8
|
|
|
|
|
|
22）Yamaguchi Y, Kanetsuna Y, Honda K, et al. Characteristic tubulointerstitial nephritis in IgG4-related disease. Hum Pathol. 2012; 43(4): 536-49
|
|
|
|
|
|
23）Raissian Y, Nasr SH, Larsen CP, et al. Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol. 2011; 22(7): 1343-52
|
|
|
|
|
|
24）Frulloni L, Lunardi C, Simone R, et al. Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med. 2009; 361(22): 2135-42
|
|
|
|
|
|
25）Kawano M, Yamada K, Kakuchi Y, et al. A case of immunoglobulin G4-related chronic sclerosing sialadenitis and dacryoadenitis associated with tuberculosis. Mod Rheumatol. 2009; 19(1): 87-90
|
|
|
|
|
|
26）Cornell LD. IgG4-related kidney disease. Curr Opin Nephrol Hypertens. 2012; 21(3): 279-88
|
|
|
|
|
|
27）Fervenza FC, Downer G, Beck LH, Jr., et al. IgG4-related tubulointerstitial nephritis with membranous nephropathy. Am J Kidney Dis. 2011; 58(2): 320-4
|
|
|
|
|
|
28）Cravedi P, Abbate M, Gagliardini E, et al. Membranous nephropathy associated with IgG4-related disease. Am J Kidney Dis. 2011; 58(2): 272-5
|
|
|
|
|